Research news

UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.

A world-class research team at UCLH and UCL has been awarded £3.76m to carry out a countrywide trial to identify accurate and quick blood tests that can diagnose dementia.

UCLH is part of an important trial researching an investigational vaccine to potentially prevent Mpox (previously known as monkey pox) and small pox. Professor Vincenzo Libri is leading the study at the NIHR UCLH Clinical Research Facility which is aiming to recruit 350 people at sites across the UK.

UCLH and UCL researchers have successfully completed a world-first trial of a therapy designed to restore hearing loss.

A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.